Abstract

The peculiarity of the pediatrics and adolescent age groups with the presence of congenital defects, genetic variance, developmental as well as puberty issues creates unique group of humans. This peculiarity of the pediatric and adolescent age groups can be easily explored when we discuss implanting defibrillator devices during this time of the human life. This chapter is devoted for Psychological, Emotional, Social and Cognitive Aspects of Implantable cardioverter Defibrillators in children and adolescents. The true impact of childhood ventricular fibrillation as well as milestones of professional care for this age group ICD candidates is discussed. Breaking the bad news-being an art by it self- has peculiarity in childhood and adolescent disease which was given concern in this chapter. Useful information and tips to be communicated to child, youth and families are given. Clear perspective of the important events of the child with ICD and reactions to it is given with emphasis to preserve normal life style as much as possible. Psychosocial Factors and Quality of Life in Children and adolescents with Implantable Cardioverter-Defibrillators are discussed. Although no longitudinal studies of psychosocial response over time for children and adolescents are available, focus in initial studies in children and young adults which illustrate higher levels of anxiety and lower quality of life scores in patients with implantable cardioverter–defibrillators has been given. The pediatric and adolescent age-specific concerns, together with the typical ICD patient concerns such as both inappropriate and appropriate shocks and physical activity restrictions were given concern. Reduced physical functioning and lower quality of life in adolescents and the importance of creating a positive emotional perspective is emphasized. Theoretical approaches to the psychosocial adjustment of ICD recipients in different age groups with discussion of general theories of psychological adjustment to the ICD has been discussed with some depth. We emphasize on the fact that psychoeducational plans and modules are the main theme in managing the psychosocial emotional and cognitive aspects of ICDs in children and adolescents. Up to date pharmacological treatment of PTSD in children and adolescents is mentioned. Finally recommendations for future research to improve psychological, emotional, social and cognitive aspects of Implantable Cardiac devices in children and adolescents are highlighted.

Keywords

Implantable cardioverter defibrillators Children and youth Adolescents Incidence of VF in children Psychological Emotional Social and cognitive aspects Breaking bad news Quality of life (QOL) Psychosocial adjustment Psychoeducational interventions 

References

  1. 1.
    Garrett A, Hazelton SSF, Ford J, Cahill J, Nekkanti R, Deantonio H, Ottoboni L, Norton L, Wang P. Decisional balance among potential implantable cardioverter defibrillator recipients: development of the ICD-Decision Analysis Scale (ICD-DAS). Pacing Clin Electrophysiol. 2014;37:63–72.CrossRefGoogle Scholar
  2. 2.
    Samson RA, Berg RA, Bingham R. Members of the PALS task force :use of automated external defibrillators for children: an update, an advisory statement from the pediatric advanced life support task force, International Liaison Committee on Resuscitation Writing Group. Circulation. 2003;107:3250–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Mogayzel C, Quan L, Graves JR, et al. Out-of-hospital ventricular fibrillation in children and adolescents: causes and outcomes. Ann Emerg Med. 1995;25:484–91.PubMedCrossRefGoogle Scholar
  4. 4.
    Hickey RW, Cohen DM, Strausbaugh S, et al. Pediatric patients requiring CPR in the pre hospital setting. Ann Emerg Med. 1995;25:495–501.2.PubMedCrossRefGoogle Scholar
  5. 5.
    Eisenberg M, Bergner L, Hallstrom A. Epidemiology of cardiac arrest and resuscitation in children. Ann Emerg Med. 1983;12:672–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Sirbaugh PE, Pepe PE, Shook JE, et al. A prospective population-based study of the demographics, epidemiology, management and outcome of out-of-hospital pediatric cardiopulmonary arrest. Ann Emerg Med. 1999;33:174–84.PubMedCrossRefGoogle Scholar
  7. 7.
    Young KD, Seidel JS. Pediatric cardiopulmonary resuscitation: a collective review. Ann Emerg Med. 1999;33:195–205.PubMedCrossRefGoogle Scholar
  8. 8.
    Schwartz PJ, Priori SG, Dumaine R, et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med. 2000;343:262–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Losek JD, Hennes H, Glaeser PW, et al. Prehospital counter shock treatment of pediatric asystole. Am J Emerg Med. 1980;7:571–5.CrossRefGoogle Scholar
  10. 10.
    Quan L, Wentz KR, Gore EJ, et al. Outcome and predictors of outcome in pediatric submersion victims receiving prehospital care in King County Washington. Pediatrics. 1990;86:586–93.PubMedGoogle Scholar
  11. 11.
    Suominen P, Olkkola KT, Voipio V, et al. Utstein style reporting of in-hospital pediatric cardiopulmonary resuscitation. Resuscitation. 2000;45:17–25.PubMedCrossRefGoogle Scholar
  12. 12.
    Nadkarni VM, Berg RA, Kaye W, et al. Survival outcome for in-hospital pulseless cardiac arrest reported to the National Registry of CPR is better for children than adults. Crit Care Med. 2003;31:A14.Google Scholar
  13. 13.
    Billson A, Tyrrell J. How to break bad news: current. Pediatrics. 2003;13:284–7.Google Scholar
  14. 14.
    Sreeram N, Trieschmann U, de Haan E. Device therapy in children: current indications. Indian Pacing Electrophysiol J. 2008;8:S92–S104.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Dimsdale C, Dimsdale A, Ford J, Shea JB, Sears SF. My child needs or has an implantable cardioverter-defibrillator: what should i do? Circulation. 2012;126:e244–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Ittenbach RF, Cassedy AE, Marino BS, Spicer RL, Drotar D. Adherence to treatment among children with cardiac disease. Cardiol Young. 2009;19:545–51.PubMedCrossRefGoogle Scholar
  17. 17.
    Sears SF, Hazelton AG, St. Amant J, Matchett M, Kovacs A, Vazquez LD, Fairbrother D, Redfearn S, Hanisch D, Dubin A, Cannon BC, Fishbach P, Kanter R, Bryant RM. Quality of life in pediatric patients with implantable cardioverter defibrillators. Am J Cardiol. 2011;107:1023–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Sable C, Foster E, Uzark K, Bjornsen K, Canobbio J, Connolly HM, Graham TP, Curvitz MZ, Kovacs A, Meadows AK, Reid GJ, Reiss JG, Rosenbaum KN, Sagerman PH, Saidi A, Schonberg R, Shah S, Tong E, Williams RG. Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a Scientific Statement from the American Heart Association. Circulation. 2011;123:1454–85.PubMedCrossRefGoogle Scholar
  19. 19.
    DeMaso DR. Pediatric heart disease. In: Brown RT, editor. Handbook of pediatric psychology in school settings. Mahwah: Lawrence Erlbaum Associates; 2004. p. 283–98.Google Scholar
  20. 20.
    Ko D, Herbert P, Coffey C, Sedrakyan A, Curtis J, Krumholtz H. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Burke JL, Hallas CN, Clark-Carter D, White D, Connelly D. The psychosocial impact of the implantable cardioverter-defibrillator: a meta-analytic review. Br J Health Psychol. 2003;8:165–78.PubMedCrossRefGoogle Scholar
  22. 22.
    Morris PL, Badger J, Chmielewski C, Berger E, Goldberg RJ. Psychiatric morbidity following implantation of the automatic implantable cardioverter defibrillator. Psychosomatics. 1991;32:58–64.PubMedCrossRefGoogle Scholar
  23. 23.
    Cooper DK, Luceri RM, Thurer RJ, Myerburg MJ. The impact of the automatic implantable cardioverter defibrillator on quality of life. Clin Prog Electrophysiol Pacing. 1986;4:306–9.Google Scholar
  24. 24.
    Heller SS, Ormont MA, Lidagoster L, Sciacca RR, Steinberg JS. Psychosocial outcome after ICD implantation: a current perspective. Pacing Clin Electrophysiol. 1998;21:1207–15.PubMedCrossRefGoogle Scholar
  25. 25.
    Sears SF, Conti JB. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychological considerations for research and clinical care. Clin Cardiol. 2003;26:107–11.PubMedCrossRefGoogle Scholar
  26. 26.
    Vitale MB, Funk M. Quality of life in younger persons with an implantable cardioverter defibrillator. Dimens Crit Care Nurs. 1995;14:100–11.PubMedCrossRefGoogle Scholar
  27. 27.
    Irvine J, Dorian P, Baker B, O’Brien BJ, Roberts R, Gent M, Newman D, Connolly SJ. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J. 2002;144:282–9.PubMedCrossRefGoogle Scholar
  28. 28.
    McCready MJ, Exner DV. Quality of life and psychological impact of implantable cardioverter defibrillators: focus on randomized controlled trial data. Card Electrophysiol Rev. 2003;7:63–70.PubMedCrossRefGoogle Scholar
  29. 29.
    Vlay SC, Olson LC, Fricchione GL, Friedman R. Anxiety and anger in patients with ventricular tachyarrhythmias: responses after automatic internal cardioverter defibrillator implantation. Pacing Clin Electrophysiol. 1989;12:366–73.PubMedCrossRefGoogle Scholar
  30. 30.
    Pycha C, Gulledge AD, Hutzler J, Kadri N, Maloney J. Psychological responses to the implantable defibrillator: preliminary observations. Psychosomatics. 1986;27:841–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Bainger EM, Fernsler JI. Perceived quality of life before and after implantation of an internal cardioverter defibrillator. Am J Crit Care. 1995;4:36–43.PubMedGoogle Scholar
  32. 32.
    Sears SF, Todaro JF, Urizar G, Lewis TS, Sirois B, Wallace R, Sotile W, Curtis AB, Conti JB. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol. 2000;23:931–3.CrossRefGoogle Scholar
  33. 33.
    Dubin AM, Batsford WP, Lewis RJ, Rosenfeld LE. Quality-of-life in patients receiving implantable cardioverter defibrillators at or before age 40. Pacing Clin Electrophysiol. 1996;19:1555–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Sears SF, Burns JL, Handberg E, Sotile WM, Conti JB. Young at heart: understanding the unique psychosocial adjustment of young implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol. 2001;24:1113–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Sears SF, Conti JB. Implantable cardioverter-defibrillators for children and young adolescents: mortality benefit confirmed—what’s next? Heart. 2004;90(3):241–2.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Sears SF, Todaro JF, Saia TL, et al. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol. 1999;22:481–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Fitchet A, Doherty PJ, Bundy C, et al. Comprehensive cardiac rehabilitation programme for implantable cardioverter defibrillator patients: a randomized controlled trial. Heart. 2003;89:155–60.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Czosek RJ, Bonney WJ, Cassedy A, Mah DY, Tanel RE, Imundo JR, Singh AK, Cohen MI, Miyake CY, Fawley K, Marino BS. Impact of cardiac devices on the quality of life in pediatric patients. Circ Arrhythm Electrophysiol. 2012;5:1064–72.PubMedCrossRefGoogle Scholar
  39. 39.
    Czosek RJ, Meganathan K, Anderson JB, Knilans TK, Marino BS, Heaton PC. Cardiac rhythm devices in the pediatric population: utilization and complications. Heart Rhythm. 2012;9:199–208.PubMedCrossRefGoogle Scholar
  40. 40.
    Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004;15:72–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, Alexander ME, Triedman JK, Walsh EP, Friedman RA. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685–91.PubMedCrossRefGoogle Scholar
  42. 42.
    Fortescue EB, Berul CI, Cecchin F, Walsh EP, Triedman JK, Alexander ME. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004;1:150–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Harter S. Manual for the self-perception profile for children. 1985:1–25.Google Scholar
  44. 44.
    Buyan N, Türkmen MA, Bilge I, Baskin E, Haberal M, Bilginer Y, Mir S, Emre S, Akman S, Ozkaya O, Fidan K, Alpay H, Kavukcu S, Sever L, Ozçakar ZB, Dogrucan N. Quality of life in children with chronic kidney disease (with child and parent assessments). Pediatr Nephrol. 2010;25:1487–96.PubMedCrossRefGoogle Scholar
  45. 45.
    Theunissen NC, Vogels TG, Koopman HM, Verrips GH, Zwinderman KA, Verloove-Vanhorick SP, Wit JM. The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res. 1998;7:387–97.PubMedCrossRefGoogle Scholar
  46. 46.
    White-Koning M, Arnaud C, Dickinson HO, Thyen U, Beckung E, Fauconnier J, McManus V, Michelsen SI, Parkes J, Parkinson K, Schirripa G, Colver A. Determinants of child-parent agreement in quality-of-life reports: a European study of children with cerebral palsy. Pediatrics. 2007;120:e804–14.PubMedCrossRefGoogle Scholar
  47. 47.
    Dunbar SB, Dougherty CM, Sears SF, Carroll DL, Goldstein NE, Mark DB, McDaniel G, Pressler SJ, Schron E, Wang P, Zeigler VL. A scientific statement from the American Heart Association, Endorsed by the Heart Rhythm Society and the American Association of Critical-Care Nurses, on behalf of the American Heart Association Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Council on Cardiovascular Disease in the young educational and psychological interventions to improve, outcomes for recipients of implantable cardioverter defibrillators and their families. Circulation. 2012;126:2146–72.PubMedCrossRefGoogle Scholar
  48. 48.
    Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) [published correction appears in Circulation. 2009;120:e33]. Circulation. 2008;117:2820–40.CrossRefGoogle Scholar
  49. 49.
    Berul CI. Implantable cardioverter defibrillator criteria for primary and secondary prevention of pediatric sudden cardiac death. Pacing Clin Electrophysiol. 2009;32(suppl 2):S67–70.PubMedCrossRefGoogle Scholar
  50. 50.
    Walsh EP. Practical aspects of implantable defibrillator therapy in patients with congenital heart disease. Pacing Clin Electrophysiol. 2008;31(suppl 1):S38–40.PubMedCrossRefGoogle Scholar
  51. 51.
    Chatrath R, Porter CB, Ackerman MJ. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Mayo Clin Proc. 2002;77:226–31.PubMedCrossRefGoogle Scholar
  52. 52.
    Pass R, Liberman L, Spotnitz H, Lamberti JJ, Hordof AJ. Implantable cardioverter defibrillators in children and adolescents: a reassessment of indications. J Am Coll Cardiol. 2003;41(Suppl A):482A.CrossRefGoogle Scholar
  53. 53.
    Almquist AK, Montgomery JV, Haas TS, Maron BJ. Cardioverter defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm. 2005;2:814–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Roquin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak PJ, Berger RD, Halperin HR, Calkins H. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2004;43:1843–52.CrossRefGoogle Scholar
  55. 55.
    Schwartz P, Spazzolini C, Priori S, Crotti L, Vicentini A, Landolina M, Gasparini M, Wilde AA, Knops RE, Denjoy I, Toivonen L, Mönnig G, Al-Fayyadh M, Jordaens L, Borggrefe M, Holmgren C, Brugada P, De Roy L, Hohnloser SH, Brink PA. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation. 2010;122:1272–82.PubMedCrossRefGoogle Scholar
  56. 56.
    Costa R, Da Silva KR, Mendonca RC, Nishioka SA, F SS, Tamaki WT, Crevelari ES, LFP M, Filho MM. Incidence of shock and quality of life in young patients with implantable cardioverter defibrillator. Arq Bras Cardiol. 2007;88:258–64.PubMedCrossRefGoogle Scholar
  57. 57.
    Burns KM, Evans F, Kaltman JR. Pediatric ICD utilization in the United States from 1997 to 2006. Heart Rhythm. 2011;8:23–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Korte T, Köditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004;27:924–32.PubMedCrossRefGoogle Scholar
  59. 59.
    Heersche JHM, Blom NA, van de Heuvel F, Blank C, Reimer AG, Clur S-A, Witsenburg M, ten Harkel ADJ. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands. Pacing Clin Electrophysiol. 2010;33:179–85.PubMedCrossRefGoogle Scholar
  60. 60.
    Celiker A, Olgun H, Karagoz T, Özer S, Özkutlu S, Alehan D. Midterm experience with implantable cardioverter-defibrillators in children and young adults. Europace. 2010;12:1732–8.PubMedCrossRefGoogle Scholar
  61. 61.
    Tomaske M, Bauersfeld U. Experience with implantable cardioverter defibrillator therapy in grown-ups with congenital heart disease. Pacing Clin Electrophysiol. 2008;31(suppl 1):S35–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Link MS, Hill SL, Cliff DL, Swygman CA, Foote CB, Homoud MK, Wang PJ, Estes NA 3rd, Berul CI. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol. 1999;83:263–6, A5–A6.Google Scholar
  63. 63.
    Shah MJ. Implantable cardioverter defibrillator-related complications in the pediatric population. Pacing Clin Electrophysiol. 2009;32(Suppl 2):S71–4.PubMedCrossRefGoogle Scholar
  64. 64.
    Sears SF, Shea JB, Conti JB. How to respond to an implantable cardioverter-defibrillator shock. Circulation. 2005;111:e380–2.PubMedCrossRefGoogle Scholar
  65. 65.
    Wilson WR, Greer GE, Grubb BP. Implantable cardioverter defibrillators in children: a single-institutional experience. Ann Thorac Surg. 1998;65:775–8.PubMedCrossRefGoogle Scholar
  66. 66.
    Zeigler VL, Corbett K, Lewis A, Gillette P. Implantable cardioverter defibrillators. In: Zeigler V, Gillette P, editors. Practical management of pediatric cardiac arrhythmias. Armonk: Futura; 2001. p. 359–409.Google Scholar
  67. 67.
    Zeigler VL, Nelms T. Almost normal: experiences of adolescents with implantable cardioverter defibrillators. J Spec Pediatr Nurs. 2009;14:142–51.PubMedCrossRefGoogle Scholar
  68. 68.
    Stefanelli CB, Bradley DJ, Leroy S, Dick M 2nd, Serwer GA, Fischbach PS. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol. 2002;6:235–44.PubMedCrossRefGoogle Scholar
  69. 69.
    DeMaso DR, Lauretti A, Spieth L, Van Der Feen JR, Jay KS, Gauvreau K, Walsh EP, Berul CI. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol. 2004;93:582–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Wójcicka M, Lewandowski M, Smolis-Bak E, Szwed H. Psychological and clinical problems in young adults with implantable cardioverter defibrillators. Kardiol Pol. 2008;66:1050–8.PubMedGoogle Scholar
  71. 71.
    Koopman H, Vrijmoet-Wiersma C, Langius J, van den Heuvel F, Clur S, Blank C, Blom N, ten Harkel A. Psychological functioning and disease related quality of life in pediatric patients with an implantable cardioverter defibrillator. Pediatr Cardiol. 2012;33:569–75.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Blom NA. Implantable cardioverter-defibrillators in children. Pacing Clin Electrophysiol. 2008;24:32–4.CrossRefGoogle Scholar
  73. 73.
    Sears SF, Amant JB, Zeigler V. Psychosocial considerations for children and young adolescents with implantable cardioverter defibrillators: an update. Pacing Clin Electrophysiol. 2009;32:80–2.CrossRefGoogle Scholar
  74. 74.
    Zeigler VL, Decker-Walters B. Determining psychosocial research priorities for adolescents with implantable cardioverter defibrillators using Delphi methodology. J Cardiovasc Nurs. 2010;25(5):398–404.PubMedCrossRefGoogle Scholar
  75. 75.
    Eicken A, Kolb C, Lange S, Brodherr-Heberlein S, Zrenner B, Schreiber C, Hess J. Implantable cardioverter defibrillator (ICD) in children. Int J Cardiol. 2006;107:30–5.PubMedCrossRefGoogle Scholar
  76. 76.
    Rahman B, Macciocca I, Sahhar M, Kamberi S, Connell V, Duncan RE. Adolescents with implantable cardioverter defibrillators: a patient and parent perspective. Pacing Clin Electrophysiol. 2011;35:62–72.PubMedCrossRefGoogle Scholar
  77. 77.
    Starks H, Trinidad SB. Choose your method: a comparison of phenomenology, discourse analysis, and grounded theory. Qual Health Res. 2007;17:1372–80.PubMedCrossRefGoogle Scholar
  78. 78.
    Shea JB. Quality of life issues in patients with implantable cardioverter defibrillators: driving, occupation, and recreation. AACN Adv Crit Care. 2004;15:478–89.Google Scholar
  79. 79.
    Tagney J, James JE, Albarran JW. Exploring the patient’s experiences of learning to live with an implantable cardioverter defibrillator (ICD) from one UK centre: a qualitative study. Eur J Cardiovasc Nurs. 2003;2:195–203.PubMedCrossRefGoogle Scholar
  80. 80.
    Dunbar SB. Psychosocial issues of patients with implantable cardioverter defibrillators. Am J Crit Care. 2005;14:294–303.PubMedGoogle Scholar
  81. 81.
    Goel AK, Berger S, Pelech A, Dhala A. Implantable cardioverter defibrillator therapy in children with long QT syndrome. Pediatr Cardiol. 2004;25:370–8.PubMedCrossRefGoogle Scholar
  82. 82.
    Lampert R, Shusterman V, Burg M, McPherson C, Batsford W, Goldberg A, Soufer R. Anger-induced T-wave alternans predicts future ventricular arrhythmias in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol. 2009;53(9):774–8. doi: 10.1016/j.jacc.2008.10.053.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Wolpe J, Plaud J. Pavlov’s contributions to behavior therapy: the obvious and not so obvious. Am Psychologist. 1997;52:966–72.CrossRefGoogle Scholar
  84. 84.
    Peterson C, Seligman M. Explanatory style and illness. J Pers. 1987;55:237–65.PubMedCrossRefGoogle Scholar
  85. 85.
    Dougherty CM, Lewis FM, Thompson EA, Baer JD, Kim W. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004;27:1594–602.PubMedCrossRefGoogle Scholar
  86. 86.
    Wallander JL, Varni JW. Adjustment in children with chronic physical disorders: programmatic research on a disability-stress—coping model. In: La Greca AM, Siegel LJ, Wallander JL, Walker CE, editors. Stress and coping in child health. New York: Guilford; 1992. p. 279–97.Google Scholar
  87. 87.
    Thompson RJ, Gustafson KE, George LK, et al. Psychological adjustment of children with cystic fibrosis: the role of child cognitive processes and maternal adjustment. J Pediatr Psychology. 1992;17:741–55.CrossRefGoogle Scholar
  88. 88.
    Wallander JL, Thompson RJ. Psychosocial adjustment of children with chronic physical conditions. In: Roberts MC, editor. Handbook of pediatric psychology. 2nd ed. New York: Guilford; 1995. p. 124–41.Google Scholar
  89. 89.
    Festinger L. A theory of social comparison processes. Hum Relations. 1954;7:117–40.CrossRefGoogle Scholar
  90. 90.
    Affleck G, Tennen H, Pfeiffer C, et al. Appraisals of control and predictability in adapting to chronic illness. J Pers Soc Psychol. 1987;53:273–9.PubMedCrossRefGoogle Scholar
  91. 91.
    Freedenberg VA, Thomas SA, Friedmann E. A pilot study of a mindfulness based stress reduction program in adolescents with implantable cardioverter defibrillators or pacemakers. Pediatr Cardiol. 2015;36(4):786–95.PubMedCrossRefGoogle Scholar
  92. 92.
    Graham P. Cognitive behavior therapy for children and families. Cambridge: Cambridge University Press; 1998.Google Scholar
  93. 93.
    Irvine J, Firestone J, Ong L, Cribbie R, Dorian P, Harris L, Ritvo P, Katz J, Newman D, Cameron D, Johnson S, Bilanovic A, Hill A, O’Donnell S, Sears S Jr. A randomized controlled trial of cognitive behavior therapy tailored to psychological adaptation to an implantable cardioverter defibrillator. Psychosom Med. 2011;73:226–33.PubMedCrossRefGoogle Scholar
  94. 94.
    Sneed NV, Finch NJ, Michel Y. The effect of psychosocial nursing intervention on the mood state of patients with implantable cardioverter defibrillators and their caregivers. Prog Cardiovasc Nurs. 1997;12:4–14.PubMedGoogle Scholar
  95. 95.
    Kohn CS, Petrucci RJ, Baessler C, Soto DM, Movsowitz C. The effect of psychological intervention on patients’ long-term adjustment to the ICD: a prospective study. Pacing Clin Electrophysiol. 2000;23:450–6.PubMedCrossRefGoogle Scholar
  96. 96.
    Carlsson E, Olsson SB, Hertervig E. The role of the nurse in enhancing quality of life in patients with an implantable cardioverter-defibrillator: the Swedish experience. Prog Cardiovasc Nurs. 2002;17:18–25.PubMedCrossRefGoogle Scholar
  97. 97.
    Frizelle DJ, Lewin RJP, Kaye G, Hargreaves C, Hasney K, Beaumont N, Moniz-Cook E. Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: a pilot study. Br J Health Psychol. 2004;9:381–92.PubMedCrossRefGoogle Scholar
  98. 98.
    Dougherty CM, Thompson EA, Lewis FM. Long-term outcomes of a telephone intervention after an ICD. Pacing Clin Electrophysiol. 2005;28:1157–67.PubMedCrossRefGoogle Scholar
  99. 99.
    Chevalier P, Cottraux J, Mollard E, Sai N, Brun S, Burri H, Restier L, Adeleine P. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. Am Heart J. 2006;151:191.PubMedCrossRefGoogle Scholar
  100. 100.
    Sears SF, Sowell LDV, Kuhl EA, Kovacs AH, Serber ER, Handberg E, Kneipp SM, Zineh I, Conti JB. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin Electrophysiol. 2007;30:858–64.PubMedCrossRefGoogle Scholar
  101. 101.
    Smeulders ESTF, van Haastregt JCM, Dijkman-Domanska BK, van Hoef EFM, van Eijk JTM, Kempen GIJM. Nurse- and peer-led self management programme for patients with an implantable cardioverter defibrillator: a feasibility study. BMC Nurs. 2007;6:6.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Lewin RJ, Coulton S, Frizelle DJ, Kaye G, Cox H. A brief cognitive behavioral preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions. Heart. 2009;95:63–9.PubMedCrossRefGoogle Scholar
  103. 103.
    Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD, O’Brien MC, Weintraub WS. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol. 2009;32:1259–71.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Crössmann A, Schulz SM, Kühlkamp V, Ritter O, Neuser H, Schumacher B, Bauer W, Pauli P. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator. Psychosom Med. 2010;72:434–41.PubMedCrossRefGoogle Scholar
  105. 105.
    Harmon RJ, Riggs PD. Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry. 1996;35:1247–9.PubMedCrossRefGoogle Scholar
  106. 106.
    Horrigan JP. Guanfacine for PTSD nightmares. J Am Acad Child Adolesc Psychiatry. 1996;35:975–6.PubMedCrossRefGoogle Scholar
  107. 107.
    Connor DF, Grasso DJ, Slivinsky MD, Pearson GS, Banga A. An open label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol. 2013;23:244–51.PubMedPubMedCentralCrossRefGoogle Scholar
  108. 108.
    Brkanac Z, Pastor JF, Storck M. Prazosin in PTSD [Case reports e Letter]. J Am Acad Child Adolesc Psychiatry. 2003;42:384–5.PubMedCrossRefGoogle Scholar
  109. 109.
    Fraleigh LA, Hendratta VD, Ford JD, Connor DF. Prazosin for the treatment of posttraumatic stress disorder-related nightmares in an adolescent male. J Child Adolesc Psychopharmacol. 2009;19:475–6.PubMedCrossRefGoogle Scholar
  110. 110.
    Oluwabusi OO, Sedky K, Bennett DS. Prazosin treatment of nightmares and sleep disturbances associated with posttraumatic stress disorder: two adolescent cases (Case Reports). J Child Adolesc Psychopharmacol. 2012;22:399–402.PubMedCrossRefGoogle Scholar
  111. 111.
    Strawn JR, Delbello MP, Geracioti TD. Prazosin treatment of an adolescent with posttraumatic stress disorder (Case Reports Letter). J Child Adolesc Psychopharmacol. 2009;19:599–600.PubMedCrossRefGoogle Scholar
  112. 112.
    Strawn JR, Keeshin BR. Successful treatment of posttraumatic stress disorder with prazosin in a young child. Ann Pharmacother. 2011;45:1590–1.PubMedCrossRefGoogle Scholar
  113. 113.
    Deans KJ, Thackeray J, Askegard-Giesmann JR, Earley E, Groner JI, Minneci PC. Mortality increases with recurrent episodes of nonaccidental trauma in children. J Trauma Acute Care Surg. 2013;75:161–5.PubMedCrossRefGoogle Scholar
  114. 114.
    Stoddard FJJ. Outcomes of traumatic exposure. Child Adolesc Psychiatr Clin N Am. 2014;23:243–56.PubMedCrossRefGoogle Scholar
  115. 115.
    Subica AM, Claypoole KH, Wylie AM. PTSD’S mediation of the relationships between trauma, depression, substance abuse, mental health, and physical health in individuals with severe mental illness: evaluating a comprehensive model. Schizophr Res. 2012;136:104–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Prince Sultan Cardiac CentreHofuf, AlhasaSaudi Arabia

Personalised recommendations